mass spectrometry
| 2 min read
Detecting tumor antigens is key to developing effective cancer diagnostics, immunotherapies, and vaccines.
| 7 min read
Achieving higher accuracy and depth in bottom-up proteomics involves navigating a multifaceted process with various steps and challenges.
| 5 min read
An ingenious chemical labeling strategy offers solutions to enhancing throughput in mass spectrometry analysis.
| 4 min read
Scientists coupled mass spectrometry imaging with spatial transcriptomics in a single tissue, allowing for new discoveries in rare samples.
Available on Demand
Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.
Available on Demand
LIVE September 13th, 2021 at 11:00 AM ET
In this webinar, Shane Needham will discuss methods to optimize protein quantification workflows and introduce a new HRAMS system, the ZenoTOF 7600.
In this webinar, Shane Needham will discuss methods to optimize protein quantification workflows and introduce a new HRAMS system, the ZenoTOF 7600.
| 1 min read
Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply.
| 3 min read
Purdue researchers apply machine learning concepts to create a new mass spec method
Page 1 of 1 - 9 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
